These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36053472)

  • 61. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W; Zhang L; Wang Z; He X; Lin H; Wang Y; Yuan J; Xie X; Zhang X; Qin Y; Huang P
    Int J Clin Pract; 2022; 2022():2726686. PubMed ID: 35989868
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
    Joung J; Oh JS; Yoon JM; Ko KO; Yoo GH; Cheon EJ
    BMC Pediatr; 2022 Aug; 22(1):474. PubMed ID: 35931986
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intravenous immunoglobulin-resistant Kawasaki disease: Risk factors in children in a middle-income country.
    Zahari N; Bah MNM; Sulieman MF; Choo HL
    Ann Pediatr Cardiol; 2023; 16(2):102-108. PubMed ID: 37767168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
    [TBL] [Abstract][Full Text] [Related]  

  • 66. C-reactive protein to albumin ratio as a prognostic tool for predicting intravenous immunoglobulin resistance in children with kawasaki disease: a systematic review of cohort studies.
    Liu J; Chen X; Yang M; Shen F; Zhu F; Jin J; Teng Y
    Pediatr Rheumatol Online J; 2024 Apr; 22(1):42. PubMed ID: 38610057
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Viral load of Torquetenovirus correlates with Sano's score and levels of total bilirubin and aspartate aminotransferase in Kawasaki disease.
    Spezia PG; Matsudaira K; Filippini F; Miyamura T; Okada K; Nagao Y; Ishida T; Sano T; Pistello M; Maggi F; Hara J
    Sci Rep; 2023 Oct; 13(1):18033. PubMed ID: 37865714
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predicting factors for refractory kawasaki disease.
    Do YS; Kim KW; Chun JK; Cha BH; Namgoong MK; Lee HY
    Korean Circ J; 2010 May; 40(5):239-42. PubMed ID: 20514335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
    Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):78. PubMed ID: 31775782
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.
    Yoshikane Y; Okuma Y; Miyamoto T; Hashimoto J; Fukazawa R; Kato T; Takeda A; Suda K; Matsushita T; Hiroe M; Imanaka-Yoshida K
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):82. PubMed ID: 34090475
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old.
    Wu S; Long Y; Chen S; Huang Y; Liao Y; Sun Y; Zhang Q; Zhang C; Yan H; Qi J; Liu X; Chen Y; Zhang Y; Du J
    Front Pediatr; 2019; 7():514. PubMed ID: 31921727
    [No Abstract]   [Full Text] [Related]  

  • 74. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Machine Learning Model to Predict Intravenous Immunoglobulin-Resistant Kawasaki Disease Patients: A Retrospective Study Based on the Chongqing Population.
    Liu J; Zhang J; Huang H; Wang Y; Zhang Z; Ma Y; He X
    Front Pediatr; 2021; 9():756095. PubMed ID: 34820343
    [No Abstract]   [Full Text] [Related]  

  • 76. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tenascin-C predicts IVIG non-responsiveness and coronary artery lesions in kawasaki disease in a Chinese cohort.
    Li Y; Xu Z; Wu L; Liang X; Zhao L; Liu F; Wang F
    Front Pediatr; 2022; 10():979026. PubMed ID: 36582508
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study.
    Okuma Y; Suda K; Nakaoka H; Katsube Y; Mitani Y; Yoshikane Y; Ichida F; Matsushita T; Shichino H; Shiraishi I; Abe J; Hiroe M; Yoshida T; Imanaka-Yoshida K
    Circ J; 2016 Oct; 80(11):2376-2381. PubMed ID: 27746411
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Egami K; Muta H; Ishii M; Suda K; Sugahara Y; Iemura M; Matsuishi T
    J Pediatr; 2006 Aug; 149(2):237-40. PubMed ID: 16887442
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-Responders to Intravenous Immunoglobulin and Coronary Artery Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children.
    Kim BY; Kim D; Kim YH; Ryoo E; Sun YH; Jeon IS; Jung MJ; Cho HK; Tchah H; Choi DY; Kim NY
    Korean Circ J; 2016 Jul; 46(4):542-9. PubMed ID: 27482264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.